Current Role and Potential of Polymeric Biomaterials in Clinical Obesity Treatment

Biomacromolecules. 2023 Aug 14;24(8):3438-3449. doi: 10.1021/acs.biomac.3c00388. Epub 2023 Jul 13.

Abstract

The rise of obesity and associated fatal diseases has taken a massive toll worldwide. Despite the existing pharmaceuticals and bariatric surgeries, these approaches manifest limited efficacy or accompany various side effects. Therefore, researchers seek to facilitate the prolonged and specific delivery of therapeutics. Or else, to mimic the essential part of "gastric bypass" by physically blocking excessive absorption via less invasive methods. To achieve these goals, polymeric biomaterials have gained tremendous interest recently. They are known for synthesizing hydrogels, microneedle patches, mucoadhesive coatings, polymer conjugates, and so forth. In this Review, we provide insights into the current studies of polymeric biomaterials in the prevention and treatment of obesity, inspiring future improvements in this regime of study.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biocompatible Materials*
  • Drug Delivery Systems / methods
  • Humans
  • Hydrogels / therapeutic use
  • Obesity* / drug therapy
  • Polymers / therapeutic use

Substances

  • Biocompatible Materials
  • Hydrogels
  • Polymers